Activation of mutantTERTpromoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of mutantTERTpromoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 50, Pages 14402-14407
Publisher
Proceedings of the National Academy of Sciences
Online
2016-11-24
DOI
10.1073/pnas.1611106113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
- (2016) Jasmina Paluncic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Reactivation of telomerase in cancer
- (2016) Semih Can Akincilar et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- TERTpromoter mutations in melanoma survival
- (2016) Eduardo Nagore et al. INTERNATIONAL JOURNAL OF CANCER
- Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression
- (2016) Ekta Khattar et al. JOURNAL OF CLINICAL INVESTIGATION
- The state of melanoma: challenges and opportunities
- (2016) Glenn Merlino et al. Pigment Cell & Melanoma Research
- Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells
- (2015) Nagarathinam Selvaraj et al. Cell Communication and Signaling
- Quantitative assessment of telomerase components in cancer cell lines
- (2015) Semih Can Akıncılar et al. FEBS LETTERS
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
- (2015) Cheryl M. Koh et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
- (2015) Yinghui Li et al. NATURE CELL BIOLOGY
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
- (2015) Elisabetta Macerola et al. VIRCHOWS ARCHIV
- Noncanonical Functions of Telomerase: Implications in Telomerase-Targeted Cancer Therapies
- (2014) Yinghui Li et al. CANCER RESEARCH
- Erk1/2 Activity Promotes Chromatin Features and RNAPII Phosphorylation at Developmental Promoters in Mouse ESCs
- (2014) Wee-Wei Tee et al. CELL
- TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
- (2014) Xiaoli Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
- (2014) Barbara Heidenreich et al. Nature Communications
- Genome-wide Kinase-Chromatin Interactions Reveal the Regulatory Network of ERK Signaling in Human Embryonic Stem Cells
- (2013) Jonathan Göke et al. MOLECULAR CELL
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- Protein Kinase Cα-Induced Derepression of the Human Luteinizing Hormone Receptor Gene Transcription through ERK-Mediated Release of HDAC1/Sin3A Repressor Complex from Sp1 Sites
- (2008) Mingjuan Liao et al. MOLECULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started